Found 95 with Last Name = 'mclellan' and Initial = 'js' TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.690nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
3D Structure (crystal)TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.30nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 2.60nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 2.60nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 4.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 6.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 47nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 71nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 183nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 365nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 641nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: 1.07E+3nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Reviral
Curated by ChEMBL
Reviral
Curated by ChEMBL
Affinity DataIC50: >2.50E+4nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 7.90nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 7.90nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 50nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 32nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 100nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.26E+3nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 158nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.60nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 126nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: <1.00E+5nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 398nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 16nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 4nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 2nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.200nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.30nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.398nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 126nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 7.90nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 40nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.60nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
